Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial

While cervix screening using cytology is recommended at 2‐ to 3‐year intervals, given the increased sensitivity of human papillomavirus (HPV)‐based screening to detect precancer, HPV‐based screening is recommended every 4‐ to 5‐years. As organized cervix screening programs transition from cytology t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottschlich, Anna, Gondara, Lovedeep, Smith, Laurie W., Cook, Darrel, Martin, Ruth Elwood, Lee, Marette, Peacock, Stuart, Proctor, Lily, Stuart, Gavin, Krajden, Mel, Franco, Eduardo L., van Niekerk, Dirk, Ogilvie, Gina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336650/
https://www.ncbi.nlm.nih.gov/pubmed/35460070
http://dx.doi.org/10.1002/ijc.34039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336650/
https://www.ncbi.nlm.nih.gov/pubmed/35460070
http://dx.doi.org/10.1002/ijc.34039

Ejemplares similares